Form 4: Wellgistics Health Director Ajjarapu Reports Significant Stock Transactions

Director Surendra Ajjarapu reports acquisition and disposal of Wellgistics Health stock, including restricted shares, impacting his direct and indirect holdings.

Summary

• On March 21, 2025, Surendra Ajjarapu, a director of Wellgistics Health, Inc. (WGRX), reported transactions involving the company's common stock.
• Ajjarapu acquired 2,882,247 shares of common stock at $0 per share and disposed of 1,822,247 shares.
• He also acquired 600,000 shares each indirectly through the Sandhya Ajjarapu Revocable Trust 2007 and Sansur Associates LLC, both at $0 per share.
• Following these transactions, Ajjarapu directly owns 1,822,247 shares, and indirectly owns 4,463,200 shares through the Sandhya Ajjarapu Revocable Trust 2007 and 3,100,000 shares through Sansur Associates LLC.
• The acquired shares are restricted stock issued under the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports transactions without indicating positive or negative implications for the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transactions could influence investor perception of the company's stock, potentially affecting shareholder value.
• The issuance of restricted stock impacts the overall equity structure of the company.

Key Dates

Keywords

Wellgistics Health, Surendra Ajjarapu, stock transactions, Form 4, beneficial ownership, restricted stock, equity incentive plan, WGRX, director